Stock listing
NYSE:NUVB Nuvation Bio Inc. Stock
Home listing (NYSE) of Nuvation Bio Inc.
Follow Nuvation Bio Inc. into a list and get an email when it puts out news.
Share price · NYSE:NUVB
$4.76 USD -0.01 (-0.2%)
Close on Oct 30, 2026
- Day range
- $4.60 – $4.81 USDOct 30, 2026
- Volume
- 5.06M sharesOct 30, 2026
- Market cap
- $1.67B USDAt the close on Oct 30, 2026 · price × 350.1M shares outstanding
- 52-week range
- $3.92 – $9.75 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $31.10M USDMedian day 4.87M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:NUVB · Home | $4.76 USD | -0.01 (-0.2%) | 5,059,887 | $4.75 | $4.805 | $4.60 | $4.77 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NYSE:NUVB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.76 | -0.01 | -0.2% | $4.75 | $4.805 | $4.60 | 5,059,887 | |
| $4.77 | +0.18 | +3.9% | $4.65 | $4.835 | $4.64 | 6,495,901 | |
| $4.59 | +0.04 | +0.9% | $4.48 | $4.60 | $4.425 | 5,213,784 | |
| $4.55 | +0.04 | +0.9% | $4.51 | $4.59 | $4.36 | 5,042,823 | |
| $4.51 | -0.06 | -1.3% | $4.62 | $4.68 | $4.48 | 3,660,066 | |
| $4.57 | -0.13 | -2.8% | $4.62 | $4.66 | $4.44 | 3,190,400 | |
| $4.70 | -0.15 | -3.1% | $4.83 | $4.91 | $4.655 | 5,805,100 | |
| $4.85 | +0.08 | +1.7% | $4.77 | $4.96 | $4.72 | 4,501,300 | |
| $4.77 | +0.29 | +6.5% | $4.51 | $4.82 | $4.46 | 6,853,000 | |
| $4.48 | +0.03 | +0.7% | $4.48 | $4.60 | $4.345 | 4,222,000 | |
| $4.45 | -0.30 | -6.3% | $4.75 | $4.76 | $4.42 | 4,471,300 | |
| $4.75 | +0.07 | +1.5% | $4.74 | $4.855 | $4.67 | 4,822,800 | |
| $4.68 | -0.04 | -0.8% | $4.66 | $4.80 | $4.61 | 3,779,000 | |
| $4.72 | -0.18 | -3.7% | $4.86 | $4.92 | $4.71 | 7,607,800 | |
| $4.90 | -0.10 | -2.0% | $4.96 | $5.005 | $4.88 | 3,182,900 | |
| $5.00 | +0.05 | +1.0% | $4.95 | $5.06 | $4.87 | 2,957,000 | |
| $4.95 | +0.09 | +1.9% | $4.80 | $4.98 | $4.625 | 9,289,800 | |
| $4.86 | -0.02 | -0.4% | $4.81 | $4.95 | $4.79 | 5,448,700 | |
| $4.88 | -0.07 | -1.4% | $4.96 | $4.97 | $4.73 | 6,653,200 | |
| $4.95 | -0.19 | -3.7% | $5.12 | $5.16 | $4.85 | 9,963,000 | |
| $5.14 | -0.42 | -7.6% | $5.66 | $5.66 | $5.03 | 14,825,000 | |
| $5.56 | -0.04 | -0.7% | $5.57 | $5.616 | $5.452 | 3,471,200 | |
| $5.60 | -0.02 | -0.4% | $5.81 | $5.825 | $5.59 | 5,547,000 | |
| $5.62 | +0.02 | +0.4% | $5.59 | $5.69 | $5.54 | 3,068,000 | |
| $5.60 | -0.14 | -2.4% | $5.68 | $5.68 | $5.48 | 4,584,700 | |
| $5.74 | +0.01 | +0.2% | $5.73 | $5.825 | $5.67 | 2,816,600 | |
| $5.73 | +0.02 | +0.4% | $5.69 | $5.78 | $5.535 | 5,705,600 | |
| $5.71 | -0.39 | -6.4% | $6.07 | $6.07 | $5.69 | 4,603,900 | |
| $6.10 | +0.03 | +0.5% | $6.26 | $6.26 | $5.955 | 4,323,000 | |
| $6.07 | +0.22 | +3.8% | $6.00 | $6.105 | $5.86 | 3,026,200 | |
| $5.85 | -0.22 | -3.6% | $6.15 | $6.18 | $5.82 | 4,433,900 | |
| $6.07 | +0.29 | +5.0% | $5.96 | $6.16 | $5.92 | 5,738,500 | |
| $5.78 | -0.02 | -0.3% | $5.80 | $5.82 | $5.655 | 2,781,200 | |
| $5.80 | -0.14 | -2.4% | $5.90 | $5.91 | $5.63 | 7,051,900 | |
| $5.94 | -0.13 | -2.1% | $5.90 | $6.135 | $5.77 | 10,029,800 | |
| $6.07 | -0.21 | -3.3% | $6.36 | $6.39 | $5.95 | 4,318,000 | |
| $6.28 | -0.24 | -3.7% | $6.44 | $6.45 | $6.17 | 7,979,800 | |
| $6.52 | -0.09 | -1.4% | $6.55 | $6.715 | $6.50 | 2,611,400 | |
| $6.61 | -0.20 | -2.9% | $6.69 | $6.746 | $6.58 | 2,541,900 | |
| $6.81 | +0.04 | +0.6% | $6.78 | $6.87 | $6.72 | 3,755,200 | |
| $6.77 | -0.16 | -2.3% | $7.03 | $7.13 | $6.65 | 5,266,900 | |
| $6.93 | +0.29 | +4.4% | $6.75 | $6.97 | $6.69 | 4,996,700 | |
| $6.64 | -0.02 | -0.3% | $6.60 | $6.95 | $6.58 | 4,843,600 | |
| $6.66 | 0.00 | 0.0% | $6.695 | $6.753 | $6.485 | 3,199,800 | |
| $6.66 | -0.33 | -4.7% | $6.90 | $6.996 | $6.625 | 3,662,000 | |
| $6.99 | +0.03 | +0.4% | $6.91 | $7.18 | $6.88 | 3,530,300 | |
| $6.96 | -0.14 | -2.0% | $7.09 | $7.12 | $6.91 | 3,439,000 | |
| $7.10 | +0.34 | +5.0% | $6.93 | $7.13 | $6.855 | 4,154,798 | |
| $6.76 | -0.17 | -2.5% | $6.82 | $6.97 | $6.66 | 3,015,226 | |
| $6.93 | +0.10 | +1.5% | $6.98 | $7.09 | $6.88 | 6,035,800 | |
| $6.83 | -0.43 | -5.9% | $7.31 | $7.31 | $6.76 | 5,312,500 | |
| $7.26 | +0.30 | +4.3% | $7.16 | $7.58 | $7.02 | 11,552,400 | |
| $6.96 | +0.48 | +7.4% | $6.57 | $6.96 | $6.44 | 6,993,700 | |
| $6.48 | +0.26 | +4.2% | $6.13 | $6.60 | $6.13 | 5,055,100 | |
| $6.22 | +0.12 | +2.0% | $6.02 | $6.28 | $5.88 | 13,326,900 | |
| $6.10 | -0.32 | -5.0% | $6.47 | $6.49 | $6.075 | 5,229,700 | |
| $6.42 | +0.05 | +0.8% | $6.42 | $6.475 | $6.315 | 2,592,700 | |
| $6.37 | -0.23 | -3.5% | $6.60 | $6.62 | $6.37 | 4,125,009 | |
| $6.60 | 0.00 | 0.0% | $6.60 | $6.62 | $6.37 | 4,838,706 | |
| $6.60 | +0.49 | +8.0% | $6.30 | $6.635 | $6.206 | 5,777,400 | |
| $6.11 | -0.26 | -4.1% | $6.06 | $6.63 | $6.01 | 8,394,900 | |
| $6.37 | -0.07 | -1.1% | $6.49 | $6.57 | $6.34 | 5,497,200 | |
| $6.44 | +0.28 | +4.5% | $6.26 | $6.535 | $6.21 | 4,652,400 | |
| $6.16 | -0.17 | -2.7% | $6.36 | $6.42 | $6.075 | 5,569,200 | |
| $6.33 | -0.37 | -5.5% | $6.68 | $6.69 | $6.295 | 4,891,100 | |
| $6.70 | +0.11 | +1.7% | $6.49 | $6.75 | $6.415 | 5,372,100 |
- Ticker
- NYSE:NUVB
- Asset type
- Stock
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Nuvation Bio to Expand Pivotal Phase 3 SIGMA Study of Safusidenib for IDH1-Mutant Glioma to Six European Countries
Latest earnings call · Aug 6, 2026
Nuvation Bio (NYSE:NUVB) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 6, 2026
Q2 2026 Earnings Presentation
Earnings · 34 slides
Calls
Upcoming
Nuvation Bio (NYSE:NUVB) Q3 2026 Earnings Call
Wed, Nov 04, 2026 · 4:30 PM ET
Register
Replays
Nuvation Bio (NYSE:NUVB) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 8:00 AM ET
Watch TranscriptNuvation Bio (NYSE:NUVB) Q1 2026 Earnings Call
Mon, May 04, 2026 · 4:30 PM ET
Watch TranscriptNuvation Bio (NYSE:NUVB) Q3 2025 Earnings Call
Mon, Nov 03, 2025 · 4:30 PM ET
Watch Transcript
Latest news
Nuvation Bio to Expand Pivotal Phase 3 SIGMA Study of Safusidenib for IDH1-Mutant Glioma to Six European Countries
Oct 29, 2026
Closed $4.77 (+3.9%) on Oct 29, 2026
Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026
Oct 21, 2026
Closed $4.70 (-3.1%) on Oct 22, 2026
Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer
Sep 16, 2026
Closed $5.78 (-0.3%) on Sep 16, 2026
Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI® (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer
Sep 15, 2026
Closed $5.80 (-2.4%) on Sep 15, 2026
Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma
Aug 20, 2026
Closed $6.83 (-5.9%) on Aug 20, 2026
Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 6, 2026
Closed $6.11 (-4.1%) on Aug 6, 2026
Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI® (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses
Aug 4, 2026
Closed $6.44 (+4.5%) on Aug 4, 2026
Nuvation Bio to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
Jul 22, 2026
Closed $6.49 (-0.9%) on Jul 23, 2026
Nuvation Bio Announces Positive Updated Phase 2 Data and Expansion of Safusidenib Clinical Program with Two New Studies to Explore Broad Spectrum of IDH1-Mutant Glioma
Jul 20, 2026
Closed $6.26 (+7.9%) on Jul 20, 2026
Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering
Jul 6, 2026
Closed $5.67 (+1.3%) on Jul 7, 2026
Financings
0.75% Convertible Senior Notes due 2032
Jul 6, 2026
Closed: US$287.5M raised
Use of proceeds: Pay about $2.2 million for additional capped call transactions; remainder for general corporate purposes including working capital and operating expenses
Decks
Q2 2026 Earnings Presentation
Earnings · 34 slides · Aug 6, 2026
Q1 2026 Earnings Presentation
Earnings · 34 slides · May 4, 2026
Investor Presentation (January 2026)
Investor deck · 37 slides · Jan 12, 2026
Investor Presentation (November 2025)
Investor deck · 36 slides · Nov 26, 2025
Nuvation Bio Inc. on 6ix
- News releases
- 33 in the last 12 months · 54 in all · newest Oct 29, 2026 · oldest 2025
- Calls
- 5 calls with a replay · 5 with a transcript · latest Aug 6, 2026
- Decks
- 17 decks · latest Aug 6, 2026
Where Nuvation Bio Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:NUVB · Home listing · This page | NYSE | United States | USD |
| BOATS:NUVB | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Nuvation Bio Inc.